LOL! Given the fact that Missling has not been raising funds before now indicates that he is confident that he won't have to raise those additional funds...
ACTC grant? More money from Retts organization or MJFox? Cash infusion from a partner?
... or maybe just old fashioned profits from selling the drug!
I agree. I am bullish on the drug itself based on the little I know about how it works and the results so far, but there are a lot more factors outside of Anavex's control -- access to cash being one of them.
It wouldn't surprise me when all is said and done for this to be fully diluted at 100M shares. Granted, if the drug works and is worth $5B or so, then $50/share isn't all that bad of a return -- even from its previous high of $14.
... which makes it a perfect time to add to one's position. The science is real and trial data bear that out. This is manipulation at its best. The cabal wants retail out... but instead they're finding that retail is adding!
News 
Market Data 
Discover 
AI
